The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Growth In Market Value Is Anticipated For The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Between 2026 And 2030?
The messenger ribonucleic acid (mRNA) synthesis and manufacturing market has experienced rapid expansion in recent years. It will grow from $5.14 billion in 2025 to $5.79 billion in 2026 at a compound annual growth rate (CAGR) of 12.6%. Historically, the market’s development was influenced by the restricted availability of mRNA synthesis platforms, early-stage research efforts in mRNA therapeutics, reliance on small-scale laboratory production, nascent regulatory frameworks, and the high cost of purification and formulation services.
The messenger ribonucleic acid (mRNA) synthesis and manufacturing market is projected for substantial expansion over the upcoming years. Its valuation is projected to reach $9.22 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 12.3%. This anticipated growth during the forecast period is primarily driven by advancements in automated mRNA synthesis technology, the expansion of commercial-grade mRNA manufacturing facilities, growing investments in vaccine and therapeutic development pipelines, an escalating demand for self-amplifying mRNA and innovative formulations, and an increase in preclinical and clinical research partnerships. Key trends anticipated during this period encompass the wider acceptance of gmp-compliant mrna synthesis, a surging need for large-scale mrna production, the enlargement of mrna therapeutics and vaccine pipelines, a sharpened emphasis on purification, capping, and tailing services, and the increasing integration of mrna-lnp formulations along with stability testing.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25832&type=smp
What Influential Factors Are Boosting The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Demand?
The messenger ribonucleic acid (mRNA) synthesis and manufacturing market is anticipated to expand due to the rising occurrence of infectious diseases. These diseases are conditions caused by harmful microorganisms like bacteria, viruses, fungi, or parasites, encompassing illnesses such as malaria, which can spread both directly and indirectly. The growing incidence of infectious diseases stems from rapid urbanization, fostering increased population density and close human interaction, thereby accelerating infection transmission. mRNA synthesis and manufacturing play a crucial role in combating infectious diseases by facilitating the swift creation and large-scale manufacturing of specific vaccines and therapeutic agents designed to elicit a particular immune response. For example, as reported by the World Health Organization, an international public health body based in Switzerland, in October 2024, about 8.2 million individuals received a new tuberculosis diagnosis in 2023, an increase from roughly 7.5 million in 2022, identifying tuberculosis as the deadliest infectious disease. Consequently, the rising occurrence of infectious diseases is fueling the expansion of the messenger ribonucleic acid (mRNA) synthesis and manufacturing market.
How Is Segment Classification Applied In The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?
The messenger ribonucleic acid (mrna) synthesis and manufacturing market covered in this report is segmented –
1) By Service Type: Messenger Ribonucleic Acid (mRNA) Drug Synthesis, Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis
2) By Scale Of Operation: Preclinical, Clinical, Commercial
3) By Therapeutic Area: Infectious Diseases, Oncology, Other Therapeutic Areas
4) By Application: Vaccine Production, Therapeutic Development, Drug Discovery, Other Applications
Subsegments:
1) By Messenger Ribonucleic Acid (mRNA) Drug Synthesis: Custom Messenger Ribonucleic Acid (mRNA) Synthesis, GMP-Grade Messenger Ribonucleic Acid (mRNA) Synthesis, Large-Scale Messenger Ribonucleic Acid (mRNA) Synthesis, Modified Messenger Ribonucleic Acid (mRNA) Synthesis, Capping And Tailing Services, Purification Services
2) By Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis: Preclinical Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis, Clinical-Grade Messenger Ribonucleic Acid (mRNA) Vaccine Synthesis, GMP-Compliant Vaccine Batch Production, Self-Amplifying Messenger Ribonucleic Acid (mRNA) Synthesis, Messenger Ribonucleic Acid (mRNA)-LNP Formulation Services For Vaccines, Stability Testing And QC Services
What Trends Are Impacting The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?
Leading companies in the messenger ribonucleic acid (mRNA) synthesis and manufacturing market are focusing on creating advanced products like co-transcriptional capping platforms to expedite preclinical research and lessen the regulatory burden. A co-transcriptional capping platform represents a proprietary technique that efficiently attaches a protective cap to messenger ribonucleic acid (mRNA) molecules during their synthesis, thereby enhancing mRNA stability, translation efficiency, and control over immunogenicity. For instance, in May 2025, GenScript, a US-based life sciences research tools company, introduced its good manufacturing practice (GMP)-like messenger ribonucleic acid (mRNA) manufacturing service. This particular service offers scalable, regulatory-aware manufacturing designed to produce high-purity, functional mRNA for investigational new drug (IND)-enabling preclinical studies, which include toxicology, biodistribution, and pharmacokinetics or pharmacodynamics (PK or PD) assessments. It operates within cleanroom-compliant, International Organization for Standardization (ISO) 7-classified environments and incorporates patented co-transcriptional capping technology. This service can deliver customized mRNA in as little as seven weeks. Such an innovation bridges the vital development gap between research-grade and full GMP manufacturing, empowering early-stage biotechnology and pharmaceutical companies to conduct regulatory-aligned studies without incurring the high costs and delays associated with traditional GMP production.
Who Are The Firms Contributing To The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Ecosystem?
Major companies operating in the messenger ribonucleic acid (mrna) synthesis and manufacturing market are Thermo Fisher Scientific Inc., Evonik Industries AG, Moderna Inc., BioNTech SE , AGC Biologics A/S, Eurofins Scientific SE, Lonza Group AG, Catalent Inc., WuXi Biologics (Cayman) Inc., Samsung Biologics Co Ltd., GenScript Biotech Corporation, Arcturus Therapeutics Holdings Inc., New England Biolabs Inc., CureVac N.V., Abzena plc, Creative Biolabs Inc., Aldevron LLC, eTheRNA immunotherapies NV, Bio-Synthesis Inc., TriLink BioTechnologies LLC
Access The Complete Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Report:
Which Area Represents The Largest Portion Of The Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market?
North America was the largest region in the messenger ribonucleic acid (mRNA) synthesis and manufacturing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the messenger ribonucleic acid (mrna) synthesis and manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=25832&type=smp
Browse Through More Reports Similar to the Global Messenger Ribonucleic Acid (mRNA) Synthesis And Manufacturing Market 2026, By The Business Research Company
Messenger Ribonucleic Acid Mrna Synthesis Raw Materials Market Report 2026
Gene Synthesis Market Report 2026
https://www.thebusinessresearchcompany.com/report/gene-synthesis-global-market-report
Mrna Therapeutics Market Report 2026
https://www.thebusinessresearchcompany.com/report/mrna-therapeutics-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model